
Introduction: Cytokeratins are specific filaments of epithelial cells. Inappropriate expression of CK5/6 and CK20 has been observed in carcinomas. Objectives: The aim of this study was to compare the immunohistochemical staining pattern and intensity of CK20 and CK5/6 in bladder urothelial carcinoma samples. Materials and Methods: In this cross-sectional study, 60 biopsy and cystectomy samples of papillary urothelial carcinoma patients (including 30 low-grade and 30 high-grade samples) who were admitted to Isfahan Khorshid educational hospital during 2019–2023 were selected using a simple random method. The samples were analyzed and compared according to the intensity and staining pattern of CK20 and CK5/6, as well as the tumor grade. Results: The predominant staining pattern of CK20 in low-grade tumors was the superficial pattern (70.0%), while in high-grade tumors, it was the diffuse or full-thickness pattern (53.3%) (P < 0.001). The most prevalent staining pattern of CK5/6 in low-grade tumors was limited to basal cells (83.3%), whereas no staining was observed in high-grade tumors (56.7%; P < 0.001). Immunoreactivity intensity for CK20 in low- and high-grade tumors was predominantly strong (46.7% and 60.0%, respectively; Mann-Whitney U = 350.5, P = 0.108). In contrast, CK5/6 intensity differed significantly between groups, being predominantly strong in low-grade tumors (80.0%) but predominantly negative in high-grade tumors (56.7%) (Mann-Whitney U = 788.0, P < 0.001). Conclusion: The staining patterns of CK20 and CK5/6 differed between low- and high-grade papillary urothelial carcinomas. Based on this observation, CK20 and CK5/6 may serve as auxiliary markers in conjunction with morphology in the diagnosis and grading of urothelial carcinoma; prospective studies with outcome data are needed to assess any prognostic value.
Introduction: Spontaneous pneumothorax is a common thoracic emergency, and surgical intervention is often required to prevent recurrence in patients at high risk or with persistent air leak. Among the available surgical strategies, pleural mechanical abrasion and chemical pleurodesis are widely used to achieve pleural symphysis, yet their relative efficacy, safety, and procedural efficiency remain a matter of clinical debate. Objectives: This retrospective case–control study was conducted to evaluate and compare the outcomes of pleural mechanical abrasion and chemical pleurodesis in patients with spontaneous pneumothorax. Patients and Methods: This retrospective case–control study included 82 patients with spontaneous pneumothorax treated at two tertiary hospitals in Karaj, Iran, between March 2019 and March 2022. Patients were allocated to pleural mechanical abrasion (n = 40) or chemical pleurodesis (n = 42) with tetracycline powder, and data on demographics, surgical indications, perioperative variables, postoperative complications, recurrence, and mortality were extracted from medical records and compared between groups. Results: The results indicated that postoperative complications, including pain, fever, hypotension, tachypnea, pneumonia, wound infection, and persistent air leak, and mortality rate did not differ significantly between groups of pleural mechanical abrasion and those receiving chemical pleurodesis (P<0.05). However, pneumothorax recurrence was significantly lower after chemical pleurodesis compared to mechanical abrasion, and chemical pleurodesis was also associated with a significantly shorter operative time (P<0.05). Hospitalization time tended to be shorter with chemical pleurodesis; however, this difference did not reach statistical significance. Conclusion: Chemical pleurodesis with tetracycline powder appears to provide superior clinical efficacy to pleural mechanical abrasion for spontaneous pneumothorax, by reducing recurrence and operative time while maintaining a similar safety profile. These results support chemical pleurodesis as a preferable surgical option in appropriately selected patients.
Introduction: Red cell distribution width (RDW), a parameter traditionally used to assess anemia, has emerged as a potential prognostic biomarker in various cancers, including breast cancer. Studies suggested that elevated RDW levels are associated with worse outcomes in terms of overall survival (OS) and progression-free survival (PFS). Objectives: This study aims to explore the utility of RDW as a predictive marker for 5-year OS and PFS in breast cancer patients. Patients and Methods: This retrospective cohort study investigated the prognostic significance of RDW as a predictive marker for 5-year OS and PFS in breast cancer patients. Conducted on 144 women treated at Shariati hospital and the cancer institute of Imam Khomeini hospital in Tehran, Iran, between 2011 and 2016, the study collected demographic, clinical, and pathological data from patient records and pathology reports. RDW values were derived from routine blood tests, while survival outcomes were assessed through phone interviews with patients or their families. The primary outcome focused on the association between RDW levels and 5-year OS, while the secondary outcome examined its correlation with 5-year PFS. Results: The results revealed that higher RDW was significantly associated with poorer outcomes of both OS and PFS, with an odds ratio (OR) of 1.89 and 1.41, respectively. The receiver operating characteristic (ROC) curve analysis indicated that, for patients with no 5-year OS, RDW demonstrated an area under the curve (AUC) of 0.783, ranging from 0.671 to 0.895. Similarly, for patients with no 5-year PFS, RDW showed an AUC of 0.679 (0.576-0.783). Conclusion: These findings highlight RDW as a potential prognostic biomarker for breast cancer survival outcomes, with higher RDW values correlating with poorer prognosis in terms of both OS and PFS.
Fracture healing involves coordinated phases of inflammation, callus formation, and remodeling, regulated by complex interactions among immune mediators, bone cells, and vascular networks. Disruption of these processes can result in delayed union or nonunion, a significant orthopedic challenge. This review synthesizes current evidence on normal repair physiology, nonunion mechanisms, biomarkers, and emerging therapies. Key topics include immune cell and cytokine dynamics, extracellular matrix (ECM) deposition, angiogenesis, and osteoclast-osteoblast coordination; pathophysiological drivers of nonunion such as persistent inflammation, impaired osteogenesis, macrophage polarization imbalance, microvascular dysfunction, systemic risk factors, and characteristic radiological-histological profiles. The role of inflammatory, bone formation, and angiogenesis biomarkers, through gene expression and immunohistochemistry is examined, along with therapeutic strategies using growth factors, cell-based treatments, engineered scaffolds, and targeted immunomodulation. Comparative analyses of animal and in vitro models highlight their translational value and limitations, and evidence is discussed regarding conventional versus biologically driven approaches to optimize fracture repair outcomes.
Introduction: Preterm delivery is a leading cause of neonatal morbidity and mortality, and early prediction remains a clinical priority. Fetal lymphoid organs such as the thymus and spleen may reflect intrauterine stress and immune development, offering potential as noninvasive markers. Objectives: This study evaluated their diagnostic value in predicting delivery time. Patients and Method: This cross-sectional study was conducted at Imam Khomeini Hospital, Tehran, Iran, between August 2025 and February 2026. Using a simple randomized sampling method, 108 pregnant women with singleton gestations were enrolled at the time of delivery. Demographic and clinical data were collected through maternal interviews and review of medical records, while fetal thymus and spleen dimensions (length, width, and circumference) were measured immediately after birth by sonography performed by a gynecologist. Statistical analyses were conducted using SPSS version 27 to assess the association and diagnostic performance of fetal thymus and spleen size in predicting preterm delivery. Results: Out of 108 pregnant women, 56 had term and 52 preterm deliveries. Fetal thymus size showed a significant inverse association with preterm delivery, with each 1-mm increase in thymus length (adjusted odds ratio [OR] = 0.75, 95% CI: 0.62-0.91), width (adjusted OR = 0.77, 95% CI: 0.63-0.93), and circumference (adjusted OR = 0.87, 95% CI: 0.77-0.97) reducing the odds of preterm birth. In contrast, larger spleen dimensions were directly associated with higher risk, as reflected by adjusted ORs of 1.16 (95% CI: 1.04-1.28) for length, 1.19 (95% CI: 1.02-1.39) for width, and 1.17 (95% CI: 1.06-1.26) for circumference. Conclusion: The findings suggest that a smaller thymus and a larger spleen appear to be associated with an increased likelihood of preterm birth occurring. Therefore, we concluded that fetal thymus and spleen measurements may serve as useful predictors of preterm delivery.